Study finds common, targetable mechanism which tumors use to suppress immune responses
A new study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumors from immune detection and destruction.
Materials provided by Ludwig Institute for Cancer Research. Note: Content may be edited for style and length.
Source link aaaaa